ARS Pharmaceuticals, Inc. (SPRY)
5.89
-0.14
(-2.32%)
USD |
NASDAQ |
Aug 28, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Price : 5.89 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 6.00 | 6.03 | 5.855 | 5.89 | 1.190M |
| Aug 27, 2026 | 6.03 | 6.12 | 5.89 | 6.03 | 1.191M |
| Aug 26, 2026 | 5.70 | 6.09 | 5.67 | 6.03 | 1.164M |
| Aug 25, 2026 | 5.40 | 5.76 | 5.39 | 5.72 | 1.716M |
| Aug 24, 2026 | 5.40 | 5.46 | 5.20 | 5.35 | 1.937M |
| Aug 21, 2026 | 5.52 | 5.60 | 5.465 | 5.505 | 1.268M |
| Aug 20, 2026 | 6.30 | 6.35 | 5.50 | 5.505 | 2.114M |
| Aug 19, 2026 | 6.42 | 6.58 | 6.35 | 6.38 | 1.213M |
| Aug 18, 2026 | 6.12 | 6.52 | 6.12 | 6.30 | 1.945M |
| Aug 17, 2026 | 5.62 | 6.285 | 5.575 | 6.24 | 2.505M |
| Aug 14, 2026 | 5.10 | 5.84 | 5.00 | 5.65 | 5.046M |
| Aug 13, 2026 | 6.08 | 6.19 | 5.90 | 6.10 | 1.979M |
| Aug 12, 2026 | 5.96 | 6.075 | 5.810 | 6.05 | 1.314M |
| Aug 11, 2026 | 5.98 | 5.98 | 5.80 | 5.95 | 1.352M |
| Aug 10, 2026 | 6.06 | 6.185 | 5.80 | 5.91 | 1.330M |
| Aug 07, 2026 | 5.60 | 6.16 | 5.575 | 6.16 | 2.156M |
| Aug 06, 2026 | 5.38 | 5.60 | 5.38 | 5.55 | 1.265M |
| Aug 05, 2026 | 5.32 | 5.46 | 5.220 | 5.36 | 2.543M |
| Aug 04, 2026 | 5.50 | 5.50 | 5.23 | 5.32 | 1.931M |
| Aug 03, 2026 | 5.08 | 5.485 | 4.910 | 5.46 | 2.144M |
| Jul 31, 2026 | 5.55 | 5.605 | 5.11 | 5.13 | 2.083M |
| Jul 30, 2026 | 5.80 | 5.852 | 5.48 | 5.63 | 1.627M |
| Jul 29, 2026 | 5.60 | 5.85 | 5.350 | 5.83 | 6.439M |
| Jul 28, 2026 | 5.72 | 6.01 | 5.66 | 5.67 | 1.354M |
| Jul 27, 2026 | 6.00 | 6.06 | 5.62 | 5.76 | 1.820M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Passage Bio, Inc. | 4.52 |
| Vertex Pharmaceuticals, Inc. | 541.69 |
| Capricor Therapeutics, Inc. | 9.59 |
| Kyntra Bio, Inc. | 8.02 |
| Zentalis Pharmaceuticals, Inc. | 3.80 |
Price Related Metrics
| PS Ratio | 4.993 |
| PEG Ratio | -0.0079 |
| Price to Book Value | 46.81 |
| Earnings Yield | -36.89% |
| Market Cap | 585.69M |
| PEGY Ratio | -0.0079 |